Last quarter (Q3 2023), NeuroPace's total revenue was $16.43M, an increase of 47.23% from the same quarter last year. In Q3, NeuroPace's net income was $-7.26M. See NeuroPace’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 60.20M	$ 45.52M	$ 45.18M	$ 41.14M	$ 36.97M
Cost of Revenue	$ 8.62M	$ 13.03M	$ -11.75M	$ 10.87M	$ 10.51M
Gross Profit	$ 43.38M	$ 32.49M	$ 33.44M	$ 30.27M	$ 26.46M
Operating Expense	$ 37.98M	$ 73.29M	$ -57.17M	$ 43.32M	$ 48.49M
Operating Income	$ -31.98M	$ -40.79M	$ -23.74M	$ -13.05M	$ -22.03M
Net Non Operating Interest Income Expense	$ -5.19M	$ -5.95M	$ -6.96M	$ -11.45M	$ -9.22M
Other Income Expense	$ 726.00K	$ 337.00K	$ 5.38M	$ 218.00K	$ 1.28M
Pretax Income	$ -37.90M	$ -47.08M	$ -36.08M	$ -24.28M	$ -29.97M
Tax Provision	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -37.90M	$ -47.08M	$ -36.08M	$ -24.05M	$ -29.97M
Basic EPS	$ -1.49	$ -1.91	$ -2.17	$ -1.74	$ -2.70
Diluted EPS	$ -1.49	$ -1.91	$ -2.17	$ -1.74	$ -2.70
Basic Average Shares	$ 101.18M	$ 24.59M	$ 16.61M	$ 11.10M	$ 11.10M
Diluted Average Shares	$ 101.18M	$ 24.59M	$ 16.61M	$ 11.10M	$ 11.10M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 46.60M	$ 86.31M	$ -68.92M	$ 54.19M	$ 59.00M
Net Income From Continuing And Discontinued Operation	$ -37.90M	$ -47.08M	$ -36.08M	$ -24.28M	$ -29.97M
Normalized Income	-	-	-	$ -24.28M	$ -29.97M
Interest Expense	-	-	-	$ 11.49M	$ 9.48M
EBIT	$ -31.21M	$ -39.55M	$ -29.12M	$ -12.79M	$ -20.49M
EBITDA	$ -28.98M	$ -36.27M	$ -28.55M	$ -12.48M	$ -20.07M

Currency in USD

NeuroPace Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing